Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms

Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms

Heart failure is the leading cause of death worldwide. Compound Danshen Dripping Pill (CDDP) or CDDP combined with simvastatin has been widely used to treat patients with myocardial infarction and other cardiovascular diseases in China. However, the effect of CDDP on hypercholesterolemia/atheroscler...

Full description

Bibliographic Details
Main Authors: Yanfang Yang, Ke Feng, Liying Yuan, Yuxin Liu, Mengying Zhang, Kaimin Guo, Zequn Yin, Wenjia Wang, Shuiping Zhou, He Sun, Kaijing Yan, Xijun Yan, Xuerui Wang, Yajun Duan, Yunhui Hu, Jihong Han
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Acta Pharmaceutica Sinica B
Subjects:
Compound danshen dripping pill
Heart failure
Hypercholesterolemia
Atherosclerosis
Simvastatin
ApoE–/–LDLR–/– mice
Online Access:http://www.sciencedirect.com/science/article/pii/S2211383522004798

Internet

http://www.sciencedirect.com/science/article/pii/S2211383522004798

Similar Items